Purchase Order N3239815P0345
- Not listed
- This is a $149,578.00 firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a Defense agency, to Roche Diagnostics Corporation for the procurement of LIGHTCYCLER URACIL-DNA equipment and supplies. The contract has an ultimate completion date of August 28, 2015 and was awarded on August 7, 2015, without a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide LIGHTCYCLER URACIL-DNA GLYCOSYLASE, 1.5ML. The potential value of the contract is $148,722.00, with a completion date of March 9, 2018. This contract was not set aside for any specific business type. Roche Diagnostics Corporation has previously received prime contract awards and subcontract awards from various...
- This federal contract award was made by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Roche Diagnostics Corporation. The $149,578 firm-fixed-price purchase order is for the supply of LightCycler uracil-DNA glycosylase and a DNTP blend reagent. The award does not have a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The company has...
- The U.S. Department of the Navy, Bureau of Medicine and Surgery, awarded a $149,552.00 firm fixed price purchase order contract to Roche Diagnostics Corporation for LIGHTCYCLER URACIL. This award does not have a set-aside designation. Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment, has received multiple federal contract awards to provide critical care analyzers, reagents, test kits, and associated products and...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer, to provide LightCycler Uracil-DNA Glycosylase products. The $147,918.00 contract has a completion date of October 15, 2019 and did not utilize a set-aside designation. Roche Diagnostics, also known as Roche Diagnostics Corp, has held multiple federal contracts to supply medical equipment, reagents, and testing services...
- This is a firm fixed-price purchase order awarded by the Plains Area division of a civilian federal agency to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for a LIGHTCYCLER SERVICE AGREEMENT with a ceiling value of $5,500.00 and an ultimate completion date of August 8, 2019. The contract was awarded on August 22, 2018 and was not set aside. Roche Diagnostics Corporation is a major provider...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide two specific laboratory products - the LightCycler Uracil-DNA Glycosylase 1.5mL and the KIT RMS dNTP Blend. This sole-source contract, valued at $148,748.00, was procured under the commercial items guidelines of Federal Acquisition Regulation (FAR) Part 12. The contract has no set-aside designation. Roche...
- This federal contract award is to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, valued at $147,944.00, is a firm fixed price purchase order from the Department of the Navy Bureau of Medicine and Surgery. The award provides for the delivery of two specific medical diagnostic products - Light Cycler Uracil-NDA Glycosylase and a Kit...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $130,670.00 firm fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the supply of LightCycler Uracil-DNA Glycosylase and dNTP Blend kits. This order was awarded without a set-aside designation, as a sole-source award under Federal Acquisition Regulation (FAR) Part 12, Commercial Items. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
- This contract award to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, is for the delivery of LIGHTCYLER URACIL-DNA glycosylase and DNTP BLEND products to the Department of the Navy Bureau of Medicine and Surgery. The $248,190.00 firm fixed price purchase order was awarded on July 20, 2021 with a completion date of August 6, 2021. No set-aside was used for this award. Roche Diagnostics is an established federal contractor, holding multiple General Services...
This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Roche Diagnostics Corporation. The contract, valued at $149,578.00, is for the procurement of LIGHTCYCLER URACIL-DNA products. The contract does not have a set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. Through this contract and other federal awards, Roche has provided critical care analyzers, reagents, test kits, and laboratory equipment, supplies, and services to various government agencies, including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services. This contract is part of Roche's broader portfolio of Indefinite Delivery Contracts and Blanket Purchase Agreements with federal agencies, which streamline the acquisition of essential medical equipment and consumables.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($100) | 1/6/21 | |
| Not listed | Not listed | $149.7k | 5/7/15 |